» Articles » PMID: 33609782

Inflammation Control and Improvement of Cognitive Function in COVID-19 Infections: is There a Role for Kynurenine 3-monooxygenase Inhibition?

Overview
Specialty Pharmacology
Date 2021 Feb 20
PMID 33609782
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The novel respiratory virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), emerged during late 2019 and spread rapidly across the world. It is now recognised that the nervous system can be affected in COVID-19, with several studies reporting long-term cognitive problems in patients. The metabolic pathway of tryptophan degradation, known as the kynurenine pathway (KP), is significantly activated in patients with COVID-19. KP metabolites have roles in regulating both inflammatory/immune responses and neurological functions. In this review, we speculate on the effects of KP activation in patients with COVID-19, and how modulation of this pathway might impact inflammation and reduce neurological symptoms.

Citing Articles

Sensitive Detection of Kynurenic Acid from Biological Fluids Using a Flexible Electrochemical Platform Based on Gold Nanoparticles and Reduced Graphene Oxide.

Macovei D, Tertis M, Bogdan D, Suciu M, Barbu-Tudoran L, Cristea C Int J Mol Sci. 2025; 26(3).

PMID: 39940684 PMC: 11817856. DOI: 10.3390/ijms26030913.


Metabolic predictors of COVID-19 mortality and severity: a survival analysis.

Abdallah A, Doudin A, Sulaiman T, Jamil O, Arif R, Sada F Front Immunol. 2024; 15:1353903.

PMID: 38799469 PMC: 11127595. DOI: 10.3389/fimmu.2024.1353903.


Quantitative LC-MS study of compounds found predictive of COVID-19 severity and outcome.

Roberts I, Muelas M, Taylor J, Davison A, Winder C, Goodacre R Metabolomics. 2023; 19(11):87.

PMID: 37853293 PMC: 10584727. DOI: 10.1007/s11306-023-02048-0.


Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction.

Lodge S, Lawler N, Gray N, Masuda R, Nitschke P, Whiley L Int J Mol Sci. 2023; 24(14).

PMID: 37511373 PMC: 10380980. DOI: 10.3390/ijms241411614.


Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19.

Garcia-Castro A, Roman-Gutierrez A, Castaneda-Ovando A, Carino-Cortes R, Acevedo-Sandoval O, Lopez-Perea P Foods. 2023; 11(20).

PMID: 37430980 PMC: 9601750. DOI: 10.3390/foods11203231.


References
1.
Rover S, Cesura A, Huguenin P, Kettler R, Szente A . Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. J Med Chem. 1998; 40(26):4378-85. DOI: 10.1021/jm970467t. View

2.
Fontana R, Bieliauskas L, Back-Madruga C, Lindsay K, Kronfol Z, Lok A . Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol. 2005; 43(4):614-22. DOI: 10.1016/j.jhep.2005.04.006. View

3.
Weinstein A, Estep J, de Avila L, Curry M, Golabi P, Escheik C . Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study. J Neuroimmunol. 2019; 335:577022. DOI: 10.1016/j.jneuroim.2019.577022. View

4.
Gupta A, Madhavan M, Sehgal K, Nair N, Mahajan S, Sehrawat T . Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26(7):1017-1032. DOI: 10.1038/s41591-020-0968-3. View

5.
Blanco Ayala T, Lugo Huitron R, Carmona Aparicio L, Ramirez Ortega D, Gonzalez Esquivel D, Pedraza Chaverri J . Alternative kynurenic acid synthesis routes studied in the rat cerebellum. Front Cell Neurosci. 2015; 9:178. PMC: 4435238. DOI: 10.3389/fncel.2015.00178. View